PE50296A1 - Eter substituido con tiazol y oxazol biciclico - Google Patents

Eter substituido con tiazol y oxazol biciclico

Info

Publication number
PE50296A1
PE50296A1 PE1995278667A PE27866795A PE50296A1 PE 50296 A1 PE50296 A1 PE 50296A1 PE 1995278667 A PE1995278667 A PE 1995278667A PE 27866795 A PE27866795 A PE 27866795A PE 50296 A1 PE50296 A1 PE 50296A1
Authority
PE
Peru
Prior art keywords
oxazole
tiazole
eter
bicycle
substituted
Prior art date
Application number
PE1995278667A
Other languages
English (en)
Inventor
Seung Hoon Cheon
Jeffrey Nadelson
William Joseph Houlihan
Thomas D Aicher
William Ronald James Simpson
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PE50296A1 publication Critical patent/PE50296A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

SE REFIERE AL COMPUESTO DE FORMULA I DONDE: X e Y SON INDEPENDIENTEMENTE OXIGENO O AZUFRE, DE PREFERENCIA OXIGENO; Z ES -CR1R2 o -CR1R2CH2-, DE PREFERENCIA EL PRIMERO; R1 Y R2 SON INDEPENDIENTEMENTE H o ALQUILO INFERIOR, DE PREFERENCIA H o METILO; R3 ES FENILO, OPCIONALMENTE MONOSUSTITUIDO O DISUSTITUIDO POR HALO, ALQUILO INFERIOR, ALCOXI INFERIOR O TRIFLUOROMETILO, DE PREFERENCIA ES FENILO MONOSUSTITUIDO O DISUSTITUIDO POR CLORO, ESPECIALMENTE 4-CLORO o 3,4 DICLORO; R4 Y R5 SON INDEPENDIENTEMENTE HIDROGENO, HALO, ALQUILO INFERIOR, -COOR6 ENTRE OTROS; TAMBIEN SE REFIERE AL PROCEDIMIENTO DE OBTENCION QUE COMPRENDE: a) LA PREPARACION DE UN COMPUESTO DE FORMULA I DONDE R6 ES DIFERENTE DE HIDROGENO, HACIENDO REACCIONAR UN COMPUESTO DE FORMULA II CON UN COMPUESTO DE FORMULA III, DONDE R7 ES H o UN GRUPO PROTECTOR DE AMINA; O b) LA PREPARACION DE UN COMPUESTO DE FORMULA I DONDE R6 ES H, HIDROLIZANDO UN COMPUESTO DE FORMULA I EN LA CUAL R6 ES ALQUILO INFERIOR o TRIALQUILSILIL(INFERIOR)ALQUILO(INFERIOR) Y LUEGO RECUPERAR EL COMPUESTO RESULTANTE DE FORMULA I
PE1995278667A 1994-09-13 1995-09-11 Eter substituido con tiazol y oxazol biciclico PE50296A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30524994A 1994-09-13 1994-09-13

Publications (1)

Publication Number Publication Date
PE50296A1 true PE50296A1 (es) 1996-12-05

Family

ID=23180015

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1995278667A PE50296A1 (es) 1994-09-13 1995-09-11 Eter substituido con tiazol y oxazol biciclico

Country Status (26)

Country Link
EP (1) EP0702015B1 (es)
JP (1) JPH08109183A (es)
KR (1) KR960010649A (es)
CN (1) CN1130186A (es)
AT (1) ATE158585T1 (es)
AU (1) AU3055295A (es)
BR (1) BR9504004A (es)
CA (1) CA2157950A1 (es)
CO (1) CO4410332A1 (es)
CZ (1) CZ229595A3 (es)
DE (1) DE69500758T2 (es)
DK (1) DK0702015T3 (es)
ES (1) ES2108550T3 (es)
FI (1) FI954257A (es)
GR (1) GR3025405T3 (es)
HU (1) HUT73432A (es)
IL (1) IL115235A0 (es)
MY (1) MY132008A (es)
NO (1) NO953569L (es)
NZ (1) NZ272976A (es)
PE (1) PE50296A1 (es)
PL (1) PL310372A1 (es)
SI (1) SI0702015T1 (es)
SK (1) SK111195A3 (es)
TR (1) TR199501115A2 (es)
ZA (1) ZA957699B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002314744A1 (en) 2001-04-17 2002-10-28 Sepracor, Inc. Thiazole and other heterocyclic ligands and use thereof
DE10333935A1 (de) * 2003-07-25 2005-02-24 Aventis Pharma Deutschland Gmbh Neue bicyclische Cyanoheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
FR2858321B1 (fr) * 2003-07-28 2006-01-20 Servier Lab Nouveaux derives d'oximes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1249992A (en) * 1983-11-10 1989-02-14 Marcel Muller Oxazolidines
EP0590793B1 (en) * 1992-08-31 1999-10-13 Sankyo Company Limited Oxazolidine derivatives having anti-diabetic and anti-obesity properties, their preparation and their therapeutic uses
US5321036A (en) * 1993-02-10 1994-06-14 Bristol-Myers Squibb Company Thiazole and oxazole-based β3 adrenergic receptor agonists
KR0173145B1 (ko) * 1993-04-07 1999-02-01 고바야시 유키오 티아졸리딘 유도체 및 이를 함유하는 약학적 조성물

Also Published As

Publication number Publication date
FI954257A0 (fi) 1995-09-11
NZ272976A (en) 1996-09-25
CZ229595A3 (en) 1996-04-17
CA2157950A1 (en) 1996-03-14
DE69500758T2 (de) 1998-02-26
JPH08109183A (ja) 1996-04-30
AU3055295A (en) 1996-03-28
EP0702015A1 (en) 1996-03-20
KR960010649A (ko) 1996-04-20
MY132008A (en) 2007-09-28
HUT73432A (en) 1996-07-29
NO953569D0 (no) 1995-09-11
PL310372A1 (en) 1996-03-18
BR9504004A (pt) 1996-09-24
CO4410332A1 (es) 1997-01-09
DK0702015T3 (da) 1998-01-12
IL115235A0 (en) 1995-12-31
TR199501115A2 (tr) 1996-06-21
DE69500758D1 (de) 1997-10-30
EP0702015B1 (en) 1997-09-24
HU9502663D0 (en) 1995-11-28
ATE158585T1 (de) 1997-10-15
ZA957699B (en) 1997-03-13
SI0702015T1 (en) 1998-02-28
CN1130186A (zh) 1996-09-04
SK111195A3 (en) 1997-06-04
ES2108550T3 (es) 1997-12-16
GR3025405T3 (en) 1998-02-27
FI954257A (fi) 1996-03-14
NO953569L (no) 1996-03-14

Similar Documents

Publication Publication Date Title
FI103508B1 (fi) Menetelmä anti-inflammatorisen aktiivisuuden omaavien 2-substituoitujen tiatsolidinonien, oksatsolidinonien ja imidatsolidinonien 3,5-di-tert.butyyli-4-hydroksifenyylimetyleenijohdannaisten valmistamiseksi
ATE141272T1 (de) Beta-lactam-verbindungen und ihre herstellung
EA200000016A1 (ru) Гидроксициклопентанон
PE50296A1 (es) Eter substituido con tiazol y oxazol biciclico
DK0617035T3 (da) Hetero-tricyclisk-substituerede phenyl-cyclohexan-carboxylsyrederivater.
ATE182594T1 (de) Thiazolotriazol- und thiazolodiazolderivate mit fungizider aktivität
ATE110056T1 (de) Merkapto- oder acylthio- trifluoromethylamidderivate und ihre verwendung.
ECSP951532A (es) Eteres substituidos con tiazol y oxazol biciclicos
FI912828A (fi) N-oxi-imidsyraderivat.

Legal Events

Date Code Title Description
FD Application declared void or lapsed